Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

AARTIDRUGS ☆ NSE also on BSE

AARTI DRUGS LTD. · code 4481 · INE767A01016 · Pharma & Healthcare · series EQ · Daily price history

498.90 -6.85 (-1.35%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
77

ISA Signal Score: Strong setup

Buy candidate: research it further. Based on prices to 2026-11-19. Confidence 100%.

Trend100
Momentum85
52-week range95
Volume85
Risk51
Fundamentals49

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • 50-day average is rising
  • RSI 65: healthy strength

Working against it

  • Revenue fell 7% year on year

Measured reference levels (not forecasts): 20-day low 374.90, 52-week high 508.75, typical daily move 25.68, two typical moves below price 447.54.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityAverageROE 13.9%, ROCE 17.2%, debt 0.44x equity
GrowthNot knownNeeds at least 3 years of results. More years load on later visits.
ValuationCheapP/E 26.9 vs sector median 42.8, 3.6x book
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 12.7 points
RiskMediumSwings 34% a year, fell up to 29% from a peak, beta 0.69

Smart Investor Tips: AARTIDRUGS

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Confirmed uptrend: trading above both rising 50-day (Rs 435.22) and 200-day (Rs 395.62) averages.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • High 30-day annualized volatility (57%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Buy / Sell Prediction & Optimal Entry PriceWAIT FOR PULLBACK (BUY ON DIPS) (Score 87/100)

Trend is strong (+14.6% above 50-DMA), so chasing at Rs 498.90 carries pullback risk. Better entry price: wait for a dip into Rs 430.87 – Rs 457.55 (near 20/50-DMA), with review stop at Rs 363.21 and target Rs 590.01.

Optimal Buy ZoneTranche 1 (50%)Tranche 2 (50%)Stop-Loss / ReviewTarget 1 (Swing)Target 2 (Breakout)Risk : Reward
Rs 430.87 – Rs 457.55
Ideal ~Rs 444.21
Rs 457.55 Rs 430.87 Rs 363.21
ATR 5.2%
Rs 590.01 Rs 687.21 1 : 1.8
RSI 65 · Vol 4.31x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +36.3% · high 527.50 · low 356.10 · max drawdown -14.7%

Live Candlestick & TradingView Chart (AARTIDRUGS)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY24, price 19 Nov

P/E26.9sector median 42.8
P/B3.58xprice / book value
EPSRs 18.56grew 3.3% a year
Dividend yield-from saved dividend events
Debt to equity0.44xnet debt Rs 553 Cr
Sales growth-6.9%a year over 1 years
Profit growth3.1%a year over 1 years
Operating margin12.5%net margin 6.8%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 8.75, EV/EBITDA 16.2. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY24 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 91/100
Total Debt / Loans Rs 562 Cr Reduced Rs 44.1 Cr YoY
Cash & Bank Balances Rs 9.43 Cr Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 553 Cr 23.1% of total assets
Debt to Equity & Interest Cover 0.44x D/E Interest cover: 8.0x EBIT
Operating Cash Flow (OCF) Rs 359 Cr OCF/PAT conversion: 209%
Free Cash Flow (FCF) Rs 133 Cr After Capex of Rs 226 Cr
  • Moderate Debt-to-Equity (0.44x).
  • De-leveraging: reduced total debt by Rs 44.1 Cr YoY.
  • Strong loan interest coverage (8.0x EBIT/Interest).
  • High earnings quality: Operating Cash Flow converts 146% of net profit into real cash.
  • Positive Free Cash Flow (Rs 133 Cr after Capex) available for debt reduction & dividends.

About AARTI DRUGS

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed19 Sep 2003BSE not available · NSE 19 Sep 2003
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 54.07% -0.36 pp, public 45.93%, as on 30 Sep 2026. Holder names and history

Day range494.10 to 507.45Open 507.45
52-week high527.50 -5.4% from high (13 Nov 2026)
52-week low318.95 +56.4% from low (30 Mar 2026)
Volume2.68 L 0.1x the 20-day average
RSI (14)65 neutral
Volatility (30d)57.3%annualised
318.95
527.50

Returns

1W-1.9%
1M+24.9%
3M+20.3%
6M+31.2%
1Y+10.6%
YTD+21.2%
3Y a year+1.9%
5Y a year-1.3%

Against the NIFTY 50

PeriodAARTIDRUGSNIFTY 50Difference
1M+24.9%+11.5% +13.5 pts
3M+20.3%+5.3% +15.0 pts
6M+31.2%+7.9% +23.3 pts
1Y+10.6%-2.1% +12.7 pts

Risk over the past year

Volatility34%medium
Deepest fall-29.1%from a peak
Beta0.69moves less than the index
Best day+11.9%09 Nov 2026
Worst day-5.0%04 Feb 2026
Up days46%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 7 / 9 · Fortress Balance Sheet
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 6.8% × Asset Turnover: 1.04x × Equity Multiplier: 1.90x = ROE 13.9%
✓ Positive Net Profit (PAT > 0) Rs 171 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 359 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 209% conversion
✓ Improving Return on Assets (ROA YoY) 7.0% vs 6.9%
✓ Conservative / Decreasing Debt-to-Equity 0.44x (prev 0.51x)
✓ Healthy Balance Sheet Asset Coverage 3.06x
⚠ Institutional Return on Equity (ROE >= 14%) 13.9%
✓ Stable / Expanding Profit Margin YoY 6.8% vs 6.1%
⚠ Asset Turnover Efficiency (Sales / Assets) 1.04x

Quarterly Results (Last 5 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Sales / Revenue 538560493543515
Sales QoQ % -+4.0%-11.9%+10.2%-5.3%
Operating Profit 59.769.154.259.560.3
Operating Margin (OPM %) 11.1%12.3%11.0%11.0%11.7%
Net Profit (PAT) 31.636.126.930.438.5
Profit QoQ % -+14.3%-25.5%+12.9%+26.8%
Profit YoY % ----+21.9%
Net Margin % 5.9%6.5%5.5%5.6%7.5%

Sales and profit Rs crore, consolidated

Sales growth-6.9%a year, 1Y
Profit growth+3.1%a year, 1Y
EPS growth+3.3%a year, 1Y
Avg ROE13.9%2 years

Profit and loss

Rs croreFY23FY24
Sales2,7162,529
Sales growth--6.9%
Operating profit306316
Operating margin11.3%12.5%
Other income2.194.03
Interest33.333.5
Depreciation50.351.5
Profit before tax224236
Tax rate25.8%27.1%
Net profit166171
Profit growth-+3.1%
Net margin6.1%6.8%
EPS (Rs)17.9718.56

Balance sheet

Rs croreFY23FY24
Equity (net worth)1,1921,282
Borrowings607562
Cash8.969.43
Total assets2,4212,432
Debt to equity0.51x0.44x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY23FY24
Operating Cash Flow (OCF)134359
Capital Expenditure (Capex)165226
Free Cash Flow (FCF = OCF - Capex)-30.5133
OCF / Net Profit Conversion0.81x2.09x
Total Borrowings / Loans607562
Cash & Bank Balances8.969.43
Trade Receivables (Cr)865705
Receivable Days116.22x101.70x
Inventories (Cr)516486
Inventory Days69.38x70.14x

Returns on capital

Rs croreFY23FY24
ROE13.9%13.9%
ROCE17.3%17.2%
Interest cover7.73x8.03x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. More years are loading and will appear on a later visit. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LTD 1,449.90 +0.4% - 17,769 37.7 7.6 20.2% 20.6%
AARTIPHARMAARTI PHARMALABS LIMITED 1,024.60 +1.1% - 9,285 42.8 5.3 12.3% 11.7%
BLUEJETBLUE JET HEALTHCARE LTD 516.85 -0.3% - 8,965 54.8 10.6 19.4% 23.0%
AARTIDRUGSAARTI DRUGS LTD. 498.90 -1.4% - 4,587 26.9 3.6 13.4% 6.8%
DIVISLABDIVI S LABORATORIES LTD 11,178.00 +1.2% - - - - - -
WOCKPHARMAWOCKHARDT LIMITED 2,187.00 +7.9% - - - - - -
LAURUSLABSLAURUS LABS LIMITED 2,306.00 -0.7% - - - - - -
SUNPHARMASUN PHARMACEUTICAL IND L 1,900.00 +1.5% - - - - - -
MAXHEALTHMAX HEALTHCARE INS LTD 1,040.65 +1.7% - - - - - -
CIPLACIPLA LTD 1,418.50 +0.1% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTER. L 8,738.00 -0.9% - - 64.7 - 21.1% 7.9%
DRREDDYDR. REDDY S LABORATORIES 1,400.90 +0.2% - - - - - -
Sector median- 42.86.513.4%

The 12 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is above the 50-day (short-term uptrend) Price is above its 200-day average (long-term uptrend) RSI 65: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper quarter of its 1-year range and is lower than it was on 2% of days in the past year.

Support (prices below today's)

50-day average435.22-12.8%
200-day average395.62-20.7%
20-day low368.85-26.1%
60-day low368.85-26.1%
52-week low318.95-36.1%

Resistance (prices above today's)

20-day high527.50+5.7%
60-day high527.50+5.7%
52-week high527.50+5.7%

Zones buyers often watch

Lower quarter of the 1-year range 318.95 to 371.09 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 422.00 to 474.75 A common area for dips inside an uptrend.
Around the 200-day average 383.75 to 407.49 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -29.1%. Currently -1.9% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average457.55 Price is 9.0% above
50-day average435.22 Price is 14.6% above
200-day average395.62 Price is 26.1% above
RSI (14)65Neutral
MACD (12, 26, 9)23.69Above its signal line (momentum rising)
Volatility (30d)57.3%High yearly swings

Support and resistance

R2513.50
R1506.20
Pivot500.15
S1492.85
S2486.80

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 507.45 507.45 494.10 498.90 -1.35% 268,291
2026-11-18 506.50 511.75 503.65 505.75 +0.59% 245,623
2026-11-17 504.70 509.95 495.90 502.80 +0.31% 414,076
2026-11-16 507.35 515.70 498.15 501.25 -1.20% 547,208
2026-11-13 509.20 527.50 502.90 507.35 -0.28% 1,560,298
2026-11-12 491.00 514.10 486.25 508.75 +3.84% 1,010,482
2026-11-11 497.20 507.65 484.00 489.95 -1.96% 2,530,663
2026-11-09 452.80 513.00 446.75 499.75 +11.08% 23,310,516
2026-11-06 445.15 454.80 435.10 446.75 +0.36% 369,145
2026-11-05 460.00 463.00 442.00 445.15 -2.34% 512,578
2026-11-04 492.00 496.95 440.20 455.80 -2.25% 3,160,142
2026-11-03 458.00 471.00 450.00 466.30 +2.75% 680,954
2026-11-02 445.00 463.50 441.95 453.80 +4.27% 750,107
2026-10-30 444.00 449.00 432.50 435.20 -3.07% 291,563
2026-10-29 440.00 457.95 434.25 449.00 +0.25% 951,968
2026-10-28 405.00 456.90 405.00 447.90 +11.35% 11,572,516
2026-10-27 381.00 404.80 380.85 402.25 +6.04% 324,800
2026-10-26 374.00 382.80 368.85 379.35 +1.19% 91,644
2026-10-23 380.25 386.35 370.30 374.90 -1.36% 193,036
2026-10-22 388.90 389.25 371.00 380.05 -2.20% 159,060
2026-10-21 396.00 398.30 385.00 388.60 -2.68% 93,130
2026-10-19 400.00 405.15 387.90 399.30 +0.74% 104,210
2026-10-16 396.45 399.45 392.50 396.35 -0.03% 69,625
2026-10-15 401.25 403.90 395.00 396.45 -1.04% 78,406
2026-10-14 410.05 410.25 399.90 400.60 -2.30% 103,261
2026-10-13 414.00 414.05 405.05 410.05 -0.86% 74,623
2026-10-12 415.40 421.20 411.70 413.60 +0.07% 69,107
2026-10-09 415.00 419.00 408.05 413.30 -0.17% 78,159
2026-10-08 417.80 431.65 411.30 414.00 -0.85% 246,945
2026-10-07 425.00 429.95 415.00 417.55 -2.62% 147,075
2026-10-06 421.15 430.25 414.10 428.80 +3.33% 132,855
2026-10-05 424.90 425.35 413.60 415.00 -1.43% 123,549
2026-10-01 431.05 431.05 414.30 421.00 -2.30% 171,972
2026-09-30 429.80 439.00 429.60 430.90 +0.54% 145,119
2026-09-29 427.50 444.00 422.05 428.60 -0.24% 570,194
2026-09-28 430.85 442.20 425.15 429.65 +0.53% 442,110
2026-09-25 440.00 440.95 425.00 427.40 -2.25% 212,626
2026-09-24 436.35 450.20 434.60 437.25 +0.23% 387,992
2026-09-23 428.95 443.50 428.00 436.25 +2.47% 198,653
2026-09-22 435.50 440.80 422.60 425.75 -2.24% 124,108
2026-09-21 427.70 440.85 427.70 435.50 +0.86% 114,136
2026-09-18 428.35 435.20 426.00 431.80 +0.81% 88,332
2026-09-17 419.20 437.70 419.20 428.35 +0.95% 120,340
2026-09-16 428.00 431.70 411.00 424.30 -0.48% 137,839
2026-09-15 428.00 439.90 424.00 426.35 -0.50% 143,544
2026-09-11 437.00 444.00 426.15 428.50 -1.95% 173,089
2026-09-10 426.25 439.40 422.35 437.00 +3.20% 254,738
2026-09-09 421.50 430.95 421.50 423.45 +0.46% 108,126
2026-09-08 421.50 427.90 419.20 421.50 -0.35% 60,740
2026-09-07 433.25 434.70 419.25 423.00 -2.00% 94,385
2026-09-04 429.25 443.75 426.20 431.65 +1.36% 250,307
2026-09-03 420.85 440.60 419.50 425.85 +1.93% 379,789
2026-09-02 430.00 430.00 415.85 417.80 -2.18% 170,806
2026-09-01 411.85 430.00 410.30 427.10 +3.74% 254,941
2026-08-31 423.00 423.00 409.95 411.70 -1.64% 59,488
2026-08-28 417.90 422.00 417.00 418.55 +0.16% 59,919
2026-08-27 419.95 423.00 413.90 417.90 -0.02% 81,669
2026-08-26 423.00 425.90 415.00 418.00 -0.99% 61,047
2026-08-25 423.00 426.45 415.80 422.20 +0.27% 119,365
2026-08-24 420.70 429.80 417.40 421.05 +0.87% 215,296
2026-08-21 413.45 420.00 410.10 417.40 +0.64% 171,553
2026-08-20 413.45 419.50 409.80 414.75 +1.54% 142,564
2026-08-19 415.80 417.00 407.20 408.45 -1.05% 133,354
2026-08-18 410.75 415.20 404.50 412.80 +0.50% 98,898
2026-08-17 416.30 420.70 408.25 410.75 -1.35% 147,186
2026-08-14 429.00 430.00 414.10 416.35 -2.65% 165,069
2026-08-13 433.65 440.00 425.90 427.70 -0.88% 137,728
2026-08-12 445.05 445.05 419.90 431.50 -1.79% 365,458
2026-08-11 426.00 453.65 421.50 439.35 +3.98% 1,384,949
2026-08-10 414.20 424.40 413.40 422.55 +1.53% 216,857
2026-08-07 411.00 418.15 409.85 416.20 +1.30% 90,024
2026-08-06 412.40 417.40 409.95 410.85 -0.38% 98,981
2026-08-05 414.00 415.95 408.80 412.40 -0.40% 110,719
2026-08-04 411.00 418.00 407.25 414.05 +1.67% 168,634
2026-08-03 424.00 424.00 405.00 407.25 -3.67% 383,239
2026-07-31 413.00 427.20 412.00 422.75 +2.41% 187,361
2026-07-30 414.40 420.70 411.05 412.80 +0.38% 175,980
2026-07-29 408.60 415.00 406.40 411.25 +0.72% 128,947
2026-07-28 413.40 414.40 406.10 408.30 -0.64% 71,277
2026-07-27 406.35 416.60 406.35 410.95 +1.59% 83,432
2026-07-24 409.00 410.00 401.00 404.50 -1.34% 82,935
2026-07-23 411.00 414.85 406.55 410.00 -0.49% 78,060
2026-07-22 426.70 434.00 402.90 412.00 -3.49% 311,603
2026-07-21 418.00 428.90 416.75 426.90 +2.13% 149,206
2026-07-20 417.05 422.50 410.00 418.00 -1.02% 196,390
2026-07-17 422.00 426.45 410.20 422.30 +0.57% 221,704
2026-07-16 430.00 435.25 418.75 419.90 -0.40% 289,872
2026-07-15 408.00 427.90 405.50 421.60 +3.92% 665,505
2026-07-14 396.10 413.90 395.90 405.70 +2.53% 553,563
2026-07-13 396.75 401.85 392.00 395.70 -0.28% 109,714
2026-07-10 399.65 401.65 395.00 396.80 +0.37% 76,806
2026-07-09 390.95 405.00 386.90 395.35 +2.13% 311,711
2026-07-08 385.00 398.50 382.00 387.10 -0.48% 271,147
2026-07-07 382.00 392.50 378.30 388.95 +2.44% 208,159
2026-07-06 387.00 388.25 377.55 379.70 -1.78% 88,300
2026-07-03 385.95 394.85 383.75 386.60 +0.56% 191,215
2026-07-02 376.10 388.00 376.10 384.45 +2.37% 152,506
2026-07-01 377.50 385.00 374.80 375.55 -0.62% 122,241
2026-06-30 373.90 390.85 369.00 377.90 +1.19% 469,785
2026-06-29 372.70 379.00 370.65 373.45 +0.20% 87,100
2026-06-25 374.00 377.40 371.35 372.70 +0.07% 104,310
2026-06-24 373.20 378.95 368.55 372.45 -0.76% 166,865
2026-06-23 377.45 385.20 372.00 375.30 -0.29% 375,301
2026-06-22 371.15 378.40 370.00 376.40 +1.63% 272,482
2026-06-19 372.35 375.90 368.20 370.35 +0.05% 135,646
2026-06-18 369.85 383.50 366.80 370.15 +0.67% 247,953
2026-06-17 375.00 375.00 367.00 367.70 -0.97% 73,005
2026-06-16 377.55 380.85 370.00 371.30 -1.09% 146,991
2026-06-15 378.00 379.00 370.10 375.40 +1.00% 235,592
2026-06-12 375.00 375.00 368.10 371.70 +1.07% 141,724
2026-06-11 372.00 373.45 365.30 367.75 -1.12% 57,191
2026-06-10 377.95 380.90 370.20 371.90 -1.12% 66,283
2026-06-09 365.60 379.85 365.15 376.10 +2.75% 158,021
2026-06-08 373.00 381.15 365.00 366.05 -2.87% 86,910
2026-06-05 376.00 381.65 373.00 376.85 +0.53% 106,175
2026-06-04 374.25 382.50 373.10 374.85 -0.94% 87,850
2026-06-03 382.60 384.10 372.55 378.40 -0.63% 57,062
2026-06-02 379.50 383.00 378.00 380.80 -0.55% 69,080
2026-06-01 385.90 391.05 379.00 382.90 +0.66% 78,856
2026-05-29 388.75 393.75 377.50 380.40 -2.69% 113,580
2026-05-27 394.00 398.90 390.00 390.90 -0.89% 99,307
2026-05-26 398.40 407.20 390.80 394.40 -0.01% 347,175
2026-05-25 393.00 399.00 388.60 394.45 +1.15% 137,035
2026-05-22 379.35 393.45 373.50 389.95 +2.51% 199,042
2026-05-21 384.95 384.95 378.30 380.40 -0.33% 51,470
2026-05-20 375.30 386.40 370.10 381.65 +0.87% 181,338
2026-05-19 365.90 381.70 363.00 378.35 +3.40% 214,964
2026-05-18 365.00 367.00 356.10 365.90 -0.50% 148,957

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 16 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: AARTI DRUGS LTD., ISIN INE767A01016.

Promoters and group
54.07%
-0.36 pp vs Jun 2026
Public (all, Category B)
45.93%
+0.36 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group54.43%54.07%-0.36 pp--0.65 ppPromoter holding fell. A change alone is not a sell or buy signal. Check the filing for the reason (market sale, transfer inside the group, new issue).
Public (all, Category B)45.57%45.93%+0.36 pp-+0.65 ppPublic holding rose. This is the mirror of promoter and other changes. It does not show what retail investors did.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202654.07%-0.36 pp45.93%+0.36 pp16 Oct 2026NSE
Jun 2026 revised54.43%-0.60 pp45.57%+0.60 pp20 Jul 2026NSE
Mar 202655.03%0.00 pp44.97%0.00 pp20 Apr 2026NSE
Dec 202555.03%+0.31 pp44.97%-0.31 pp21 Jan 2026NSE
Sep 202554.72%-0.50 pp45.28%+0.50 pp18 Oct 2025NSE
Jun 202555.22%-0.26 pp44.78%+0.26 pp17 Jul 2025NSE
Mar 202555.48%+0.10 pp44.52%-0.10 pp18 Apr 2025NSE
Dec 202455.38%-0.26 pp44.62%+0.26 pp20 Jan 2025NSE
Sep 202455.64%-0.03 pp44.36%+0.03 pp14 Oct 2024NSE
Jun 2024 revised55.67%-1.46 pp44.33%+1.46 pp18 Jul 2024NSE
Mar 202457.13%-0.34 pp42.87%+0.34 pp19 Apr 2024NSE
Dec 202357.47%-1.09 pp42.53%+1.09 pp19 Jan 2024NSE
Sep 202358.56%-0.14 pp41.44%+0.14 pp17 Oct 2023NSE
Jun 202358.70%-0.88 pp41.30%+0.88 pp13 Jul 2023NSE
Mar 202359.58%-0.08 pp40.42%+0.08 pp19 Apr 2023NSE
Dec 202259.66%-0.11 pp40.34%+0.11 pp20 Jan 2023NSE
Sep 202259.77%-0.21 pp40.23%+0.21 pp21 Oct 2022NSE
Jun 202259.98%+0.15 pp40.02%-0.15 pp16 Jul 2022NSE
Mar 202259.83%-0.16 pp40.17%+0.16 pp12 Apr 2022NSE
Dec 202159.99%-0.13 pp40.01%+0.13 pp10 Jan 2022NSE
Sep 202160.12%-39.88%-10 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.